Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing Connexin 43 gene locus.
Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing Connexin 43 gene locus.
复制标题
DOI:
10.1158/0008-5472.can-05-0227
复制
发表时间:
2005-11-01
期刊:
影响因子:
11.2
通讯作者:
Yorioka, N
中科院分区:
文献类型:
--
作者:
Ogawa, T;Hayashi, T;Yorioka, N
A historic deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SABLA), induces apoptosis in neoplastic cells, but its effect on gap junctional intercellular communication in relation to apoptosis was unclear. Therefore, we carried out a comparative study of the effects of two HDAC inhibitors, SAHA and trichostatin-A, on gap junctional intercellular communication in nonmalignant human peritoneal mesothelial cells (HPMC) and tumorigenic ras oncogene-transformed rat liver epithelial cells (WB-ras) that showed a significantly lower level of gap junctional intercellular communication than did HPMC. Gap junctional intercellular communication was assessed by recovery rate of fluorescence recovery after photobleaching. Treatment of HPMC with SARA at nanomolar concentrations caused a dose-dependent increase of recovery rate without inducing apoptosis. This effect was accompanied by enhanced connexin 43 (Cx43) mRNA and protein expression and increased presence of Cx43 protein on cell membrane. Trichostatin-A induced apoptosis in HPMC but was less potent than SARA in enhancing the recovery rate. In contrast, treatment of WB-ras cells with SAHA or trichostatin-A induced apoptosis at low concentrations, in spite of smaller increases in recovery rate, Cx43 mRNA, and protein than in HPMC. Chromatin immunoprecipitation analysis revealed that SARA enhanced acetylated histories H3 and H4 in the chromatin fragments associated with Cs43 gene in HPMC. These results indicate that SAHA at low concentrations selectively up-regulates Cx43 expression in normal human cells without induction of apoptosis, as a result of histone acetylation in selective chromatin fragments, in contrast to the apoptotic effect observed in tumorigenic WB-ras cells. These results support a cancer therapeutic and preventive role for specific HDAC inhibitors.